MedTrace Logo

Green Light and Transcranial Direct Current Stimulation in Migraine Patients

NCT06212869 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-03-05

No results posted yet for this study

Summary

There is a lack of evidence on the clinical outcome of green light exposure, as it is the emerging, novel proposal of treatment. There are a lot of researches present with small sample size which should be done on large population. In last conducted studies, session numbers of the applied modality are less. There is no comparison of tDCS with green light for migraine. The literature suggested the neuromodulation influenced by these interventions that may result in reduction of migraine.

Conditions

Interventions

DEVICE

Transcranial direct current stimulation

tDCS group will give active tDCS with the prescribed medications for 20 minute. The intervention will conduct 3 consecutive days in a week.

DEVICE

Sham transcranial direct current stimulation

Sham tDCS group will give sham tDCS with the prescribed medications for 20 minute. The intervention will conduct 3 consecutive days in a week.

DEVICE

Green light

Green light group will give green light exposure with the prescribed medications for 1-2 hour. The intervention will conduct 5 days in a week.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Mirza Obaid Baig, MSPT · Riphah International University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-18
Primary Completion
2024-09-30
Completion
2024-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06212869 on ClinicalTrials.gov